Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Y Graeber

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
ERJ Open Research|November 5, 2025
Breaking boundaries or a small piece of the puzzle: can CFTR modulators transform bronchiectasis care?Simon Y Graeber, Freddy Frost
Lancet (London, England)|September 12, 2023
The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approachesSimon Y Graeber, Marcus A Mall
Journal of Personalized Medicine|June 2, 2021
Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic FibrosisSimon Y Graeber, Constanze Vitzthum, Marcus A Mall
The International Journal of Biochemistry & Cell Biology|February 25, 2014
Early cystic fibrosis lung disease: Role of airway surface dehydration and lessons from preventive rehydration therapies in miceMarcus A Mall, Simon Y Graeber, Mirjam Stahl, et al.
Pediatric Pulmonology|September 24, 2016
Early detection and sensitive monitoring of CF lung disease: Prospects of improved and safer imagingMarcus A Mall, Mirjam Stahl, Simon Y Graeber, et al.
American Journal of Respiratory Cell and Molecular Biology|April 18, 2013
Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung diseaseSimon Y Graeber, Zhe Zhou-Suckow, Jolanthe Schatterny, et al.
Frontiers in Cellular and Infection Microbiology|December 23, 2021
A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic FibrosisMarisa I Metzger, Simon Y Graeber, Mirjam Stahl, et al.
Molecular and Cellular Pediatrics|May 4, 2025
Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulatorsBurkhard Tümmler, Sophia Theres Pallenberg, Anna-Maria Dittrich, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 17, 2018
One time quantitative PCR detection of Pseudomonas aeruginosa to discriminate intermittent from chronic infection in cystic fibrosisSébastien Boutin, Michael Weitnauer, Selina Hassel, et al.
Frontiers in Pharmacology|May 8, 2023
Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosisLinus Piehler, Ralf Thalemann, Christine Lehmann, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
ERJ Open Research|November 5, 2025
Breaking boundaries or a small piece of the puzzle: can CFTR modulators transform bronchiectasis care?Simon Y Graeber, Freddy Frost
Lancet (London, England)|September 12, 2023
The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approachesSimon Y Graeber, Marcus A Mall
Journal of Personalized Medicine|June 2, 2021
Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic FibrosisSimon Y Graeber, Constanze Vitzthum, Marcus A Mall
The International Journal of Biochemistry & Cell Biology|February 25, 2014
Early cystic fibrosis lung disease: Role of airway surface dehydration and lessons from preventive rehydration therapies in miceMarcus A Mall, Simon Y Graeber, Mirjam Stahl, et al.
Pediatric Pulmonology|September 24, 2016
Early detection and sensitive monitoring of CF lung disease: Prospects of improved and safer imagingMarcus A Mall, Mirjam Stahl, Simon Y Graeber, et al.
American Journal of Respiratory Cell and Molecular Biology|April 18, 2013
Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung diseaseSimon Y Graeber, Zhe Zhou-Suckow, Jolanthe Schatterny, et al.
Frontiers in Cellular and Infection Microbiology|December 23, 2021
A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic FibrosisMarisa I Metzger, Simon Y Graeber, Mirjam Stahl, et al.
Molecular and Cellular Pediatrics|May 4, 2025
Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulatorsBurkhard Tümmler, Sophia Theres Pallenberg, Anna-Maria Dittrich, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 17, 2018
One time quantitative PCR detection of Pseudomonas aeruginosa to discriminate intermittent from chronic infection in cystic fibrosisSébastien Boutin, Michael Weitnauer, Selina Hassel, et al.
Frontiers in Pharmacology|May 8, 2023
Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosisLinus Piehler, Ralf Thalemann, Christine Lehmann, et al.
Pageof 6